Showing results (3571-3580 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|July 13, 2016
Management of Adverse Events Following Treatment With Anti-Programmed Death-1 AgentsJeffrey S Weber, Michael Postow, Christopher D Lao, et al.
The Oncologist|August 6, 2017
Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid CancerRevathi Kollipara, Bryan Schneider, Milan Radovich, et al.
The Oncologist|September 19, 2015
Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal CanalVan K Morris, Asif Rashid, Miguel Rodriguez-Bigas, et al.
The Oncologist|November 19, 2015
S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal TumorsCharles D Blanke, Cathy Rankin, Christopher Corless, et al.
The Oncologist|November 22, 2015
Lack of Understanding of Cervical Cancer and Screening Is the Leading Barrier to Screening Uptake in Women at Midlife in Bangladesh: Population-Based Cross-Sectional SurveyRakibul M Islam, Robin J Bell, Baki Billah, et al.
The Oncologist|December 17, 2015
Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic AlterationsSiraj M Ali, Sumanta K Pal, Kai Wang, et al.
The Oncologist|November 18, 2017
Therapeutic Potential of Afatinib for Cancers with ERBB2 (HER2) Transmembrane Domain Mutations G660D and V659EHiromasa Yamamoto, Shinichi Toyooka, Takashi Ninomiya, et al.
The Oncologist|October 29, 2017
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate ClearanceLaura B Ramsey, Frank M Balis, Maureen M O'Brien, et al.
The Oncologist|November 22, 2017
Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal CancerEmilio P Araujo-Mino, Yehuda Z Patt, Cristina Murray-Krezan, et al.
The Oncologist|November 22, 2017
Anti-Hu-Associated Autoimmune Limbic Encephalitis in a Patient with PD-1 Inhibitor-Responsive Myxoid ChondrosarcomaKyriakos P Papadopoulos, Rebecca S Romero, Gabriela Gonzalez, et al.
Pageof 571